netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Dexamethasone found 25 matches

Formulary items 4 matches
Non-formulary items 1 match
   
Open monograph to display formulary status BNF Category
  Dexamethasone
(tablets) 		Central nervous system - Drugs used in nausea and vertigo - 04.06
  Dexamethasone
(Injection) 		Central nervous system - Palliative care - 04.06
  Dexamethasone Endocrine system - Glucocorticoid therapy - 06.03.02
  Dexamethasone PHOSPHATE INJECTION Endocrine system - Glucocorticoid therapy - 06.03.02
 
Non Formulary BNF Category
  Dexamethasone  (Glensoludex®) Endocrine system - Glucocorticoid therapy - 06.03.02


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (08.01.05)
link in drug section NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema (11.04.01)
link in drug section NICE TA229: Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (11.04.01)
link in drug section NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema (11.04.01)
link in drug section NICE TA349: Dexamethasone intravitreal implant for treating diabetic macular oedema (11.04.01)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.99.99.99)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (13.05.03)
link in drug section NICE TA460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)
link in drug section NICE TA505: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (08.02.04)
link in drug section NICE TA505: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (08.02.04)
link in drug section NICE TA505: Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (08.01.05)
link in drug section NICE TA573: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)
link in drug section NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (08.02.04)
link in drug section NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (08.02.04)
link in drug section NICE TA587: Lenalidomide plus dexamethasone for previously untreated multiple myeloma (08.02.04)
link in drug section NICE TA587: Lenalidomide plus dexamethasone for previously untreated multiple myeloma (08.02.04)
link in drug section NICE TA658: Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma (08.01.05)
link in drug section NICE TA695: Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma (08.01.05)
link in drug section Primary care summary - Dexamethasone in the treatment of COVID-19 (06.03.02)
link in drug section Primary care summary - Dexamethasone in the treatment of COVID-19 (04.06)


 
netFormulary